Nuchal translucence incorporated into a one-stage multifactorial screening model for Down syndrome prediction at second-trimester pregnancy

Ultrasound in Medicine and Biology

Volumn 29, Issue 12, 2003, Pages 1667-1674

  Hung, Jeng Hsiu ^a   Fu, Chong Yau ^b   Yuan, Chiou Chung ^a,b   Chen, Cheng Li ^a,b   Yang, Man Li ^a,b   Shu, Li Ping ^a   Wu, Chih Chieh ^a  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Down syndrome; Nuchal translucency

Indexed keywords

BIOCHEMISTRY; BODY FLUIDS; DISEASES; GENES; HEALTH RISKS; HORMONES; PROBABILITY; PROTEINS; REGRESSION ANALYSIS;

CYTOGENETIC DIAGNOSIS;

ULTRASONICS;

ALPHA FETOPROTEIN; CHORIONIC GONADOTROPIN BETA SUBUNIT;

ADULT; ARTICLE; BIOCHEMISTRY; CALCULATION; CHROMOSOME ANALYSIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COVARIANCE; DEVICE; DOWN SYNDROME; FEMALE; FETUS ECHOGRAPHY; GESTATIONAL AGE; HIGH RISK POPULATION; HUMAN; LABORATORY DIAGNOSIS; LOGISTIC REGRESSION ANALYSIS; MATERNAL AGE; MATERNAL SERUM; PREDICTION; PRENATAL CARE; PRENATAL DIAGNOSIS; PRENATAL SCREENING; PRIORITY JOURNAL; PROBABILITY; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; SCREENING TEST; SECOND TRIMESTER PREGNANCY; STATISTICAL MODEL; TRISOMY 21;

EID: 0346492840     PISSN: 03015629     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-5629(03)01048-2     Document Type: Article

References (21)

1. Benacerraf B.R., Barss V.A., Laboda L.A. A sonographic sign for the detection in the second trimester of the fetus with Down's syndrome. Am J Obstet Gynecol. 151:1985;1078-1079.
2. Bronshtein M., Rottem S., Yoffe N., Blumenfeld Z. First-trimester and early second-trimester diagnosis of nuchal cystic hygroma by transvaginal sonography Diverse prognosis of the septated from the non-septated lesion . Am J Obstet Gynecol. 161:1989;78-82.
3. Cuckle H. Biochemical screening for Down syndrome. Eur J Obstet Gynecol Reprod Biol. 92:2000;97-101.
4. Cuckle H.S., Wald N.J., Thompson S.G. Estimating a woman's risk of having a pregnancy associated with Down's syndrome using her age and serum alpha-fetoprotein level. Br J Obstet Gynaecol. 94:1987;387-402.
5. DeLong E.R., DeLong D.M., Clarke-Pearson D.L. Comparing the area under two or more correlated receiver operating characteristic curves A nonparametric approach . Biometrics. 44:1988;837-845.
6. Fleiss J.L. Statistical method for rates & proportion. 1981;John Wiley & Sons, New York.
7. Hafner E., Schuchter K., Liebhart E., Philipp K. Results of routine fetal nuchal translucency measurement at weeks 10-13 in 4233 unselected pregnant women. Prenat Diag. 18:1998;29-34.
8. Hanley J.A., McNeil B.J. The meaning and use of the area under a receiver operating characteristic ROC curve. Radiology. 143:1982;29-36.
9. Hanley J.A., McNeil B.J. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology. 3:1983;839-843.
10. Jou H.J., Wu S.C., Li T.C., Hsu H.C., Tzeng C.Y., Hsieh E.J. Relationship between fetal nuchal translucency and crown-rump length in an Asian population. Ultrasound Obstet Gynecol. 17:2001;111-114.
11. Martinez J.M., Echevarria M., Borrell A., et al. Fetal heart rate and nuchal translucency in detecting chromosomal abnormalities other than Down syndrome. Obstet Gynecol. 92:1998;68-71.
12. Mooney R.A., Peterson C.J., French C.A., Saller D.N. Jr, Arvan D.A. Effectiveness of combining maternal serum alpha-fetoprotein and HCG in second-trimester screening program for Down syndrome. Obstet Gynecol. 84:1994;298-303.
13. Rotmensch S., Liberati M., Bronshtein M., et al. Prenatal sonographic findings in 187 fetuses with Down's syndrome. Prenat Diag. 17:2001;1001-1009.
14. SAS/STATr user's guide, version 8. 1999;SAS Institute, Cary, NC. 1-1956.
15. Schuchter K., Hafber E., Stangl G., Ogris E., Philipp K. Sequential screening for trisomy 21 by nuchal translucency measurement in the first trimester in a low-risk population. Ultrasound Obstet Gynecol. 18:2001;23-25.
16. Scott A.J., Wild C.J. Fitting logistic regression models under case control or choice based sampling. J Roy Statist Soc Ser B. 48:1986;170-182.
17. Sebire N.J., Snijders R.J.M., Davenport M., Greenough A., Nicolaides K.H. Fetal nuchal translucency thickness at 10-14 week's gestation and congenital diaphragmatic hernia. Obstet Gynecol. 90:1997;943-946.
18. Snijders R.J.M., Johnson S., Sebire N.J., Noble P.L., Nicolaides K.H. First-trimester ultrasound screening for chromosomal defects. Ultrasound Obstet Gynecol. 7:1996;216-226.
19. Swets J.A. ROC analysis applied to the evaluation of medical imaging techniques. Invest Radiol. 14:1978;109-121.
20. Theodoropoulos P., Lolis D., Papageorgiou C., et al. Evaluation of first-trimester screening by fetal nuchal translucency and maternal age. Prenat Diag. 18:1998;133-137.
21. Wald N.J., Watt H.C. Serum markers for Down's syndrome in relation to number of previous births and maternal age. Prenat Diag. 16:1996;699-703.